Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001213900-16-014716
Filing Date
2016-07-05
Accepted
2016-07-05 17:20:33
Documents
1
Period of Report
2016-06-30

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT f4063016kabatznik_icagen.html 4  
1 OWNERSHIP DOCUMENT f4063016kabatznik_icagen.xml 4 4060
  Complete submission text file 0001213900-16-014716.txt   5585
Mailing Address
Business Address
KABATZNIK CLIVE (Reporting) CIK: 0001033830 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-54748 | Film No.: 161751573

Mailing Address 4222 EMPEROR BLVD., SUITE 350 RESEARCH TRIANGLE PARK DURHAM NC 27703
Business Address 4222 EMPEROR BLVD., SUITE 350 RESEARCH TRIANGLE PARK DURHAM NC 27703 919-941-5206
Icagen, Inc. (Issuer) CIK: 0001518520 (see all company filings)

EIN.: 200982060 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 8731 Services-Commercial Physical & Biological Research